We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

Rapid Antigen Testing for SARS-CoV-2 Could Effectively Control COVID-19 Outbreak, Finds Study

By LabMedica International staff writers
Posted on 30 Aug 2021
Print article
Rapid COVID-19 antigen tests that permit new cases to isolate immediately can be important surveillance tools and effectively control COVID-19 outbreaks, according to a longitudinal comparison between antigen tests performed at home and quantitative real-time polymerase chain reaction (qRT-PCR).

Researchers at E25Bio, Inc. (Boston, MA, USA), LabCentral, Inc. (Boston, MA, USA), Harvard T. H. Chan School of Public Health (Boston, MA, USA), Mount Sinai School of Medicine (New York, NY, USA), and BioInnovation Labs, LLC (Cambridge, MA, USA) sought to validate the effectiveness of direct antigen rapid tests (DARTs) and to test whether at-home testing with DART could prevent the spread of SARS-CoV-2 in a co-working environment. The team conducted a study of high-frequency testing using inexpensive, at-home, semi-quantitative, DARTs and compared their performance with that of qRT-PCR on self-collected nasal specimens.

For the study, a total of 257 participants were enrolled who self-collected nasal swab specimens twice weekly at home during a six-month period. DART was performed at home, and the findings were compared with laboratory qRT-PCR tests. A total of 2,951 pairs of nasal swabs were self-collected by participants and tested by qRT-PCR and DART. The researchers found that that twice-weekly surveillance with DART detected infections in 15 individuals, with 96.3% sensitivity on days 0 through 3 of symptoms. Detection on day 3 is almost as effective as detection on day 1 for reducing the incidence of COVID-19, if 75% of a population is surveilled. The prevalence of disease dictates the frequency of testing and its effectiveness for controlling potential outbreaks.

COVID-19 outbreak management has been hindered by high transmission rates and limitations in testing capacity. Effective public health tools are needed for rapid and early detection. The current diagnostic standard is qRT-PCR, although its cost and long turnaround times limit its utility for widespread surveillance. However, frequent at-home testing with DART allows infected individuals to be identified and quarantined immediately. Such surveillance can prevent viral transmission in in-person work environments or other social settings, effectively controlling COVID-19 outbreaks, according to the researchers.

Related Links:
E25Bio, Inc.
LabCentral, Inc.
Harvard T. H. Chan School of Public Health
Mount Sinai School of Medicine
BioInnovation Labs, LLC

Unit-Dose Twist-Tip BFS
Gold Supplier
COVID-19 Test Cassette
Gold Supplier
CLIA Analyzer
Protein Analysis System
Octet R4

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: Medication, sepsis and inadequate blood supply to the kidneys are potential causes of AKI (Photo courtesy of Freepik)

Blood- And Urine-Based Biomarker Tests Could Identify Treatment of Acute Kidney Injury

Hospitalized patients who experience an acute kidney injury (AKI) often face unfavorable outcomes post-discharge, with limited effective treatment options. AKI can stem from various causes, such as sepsis,... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: The first ever diagnostic test accurately predicts patient response to immunotherapy (Photo courtesy of Cofactor)

Immunotherapy Predictive Test Could Spare Cancer Patients from Unnecessary Chemotherapy

In recent years, there has been a significant increase in clinical trials for new cancer drugs. However, only a select group of patients have found success with these newer immunotherapies, which utilize... Read more


view channel
Image: New method reveals bacterial reaction to antibiotics within minutes (Photo courtesy of Freepik)

New Method to Reveal Bacterial Reaction to Antibiotics in Five Minutes Could Help Create Rapid Molecular Test

Severely sick patients suffering from bacterial infections often require immediate treatment to prevent serious health complications, making it vital for physicians to quickly identify the appropriate antibiotic.... Read more


view channel
Image: navify digital solutions can helping labs mitigate unique quality challenges (Photo courtesy of Roche)

Cloud-Based Digital Solution Allows Labs to Track Test Samples along Entire Diagnostic Journey

Diagnosing a disease involves a meticulous procedure of monitoring a patient's diagnostic sample throughout its entire journey, which aids in clinical decision-making. However, there aren't any standardized... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.